en

PRODUCT DETAIL

Bendamustine Kabi 2,5 mg/ml

Code 1287C
MA number 44/0433/16-S
Product Form: plc ifc 1x25 mg (liek.inj.skl.)
MA Status: D - Marketing Authorisation valid for an unlimited period
Type of procedure: Decentralised
MAH, country: Fresenius Kabi s.r.o., Czechia
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01A ALKYLATING AGENTS
L01AA Nitrogen mustard analogues
L01AA09 Bendamustine
Shelf life: 36
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 28.09.2016
SPC: SPC_Bendamustine Kabi 2,5 mg_ml_06.2024.pdf  
PIL: PIL_Bendamustine Kabi 2,5 mg_ml_06.2024.pdf  
Safety feature Yes
Data update: 04.05.2022
eu-flag.png sk-flag.png